Metric Finance
LearnFAQ
LearnFAQ

Learn / PRGO

NYSE: PRGO

PERRIGO Co plc (PRGO) stock, explained like you're 5

PERRIGO Co plc trades on the New York Stock Exchange under the ticker PRGO. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

Ticker
PRGO
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Mid cap, about 2.1 billion dollars

Is PERRIGO Co plc a small, medium or large cap company?

No. PERRIGO Co plc is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How PERRIGO Co plc makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves PRGO stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Perrigo Company plc (PRGO) Stock Price, News, Quote & History (Yahoo! Finance Canada)
  • Perrigo Co. PLC stock outperforms competitors on strong trading day (MarketWatch)
  • Perrigo (PRGO) Stock May Be Undervalued Based On Sales Today (Yahoo Finance)
  • Perrigo (NYSE:PRGO) Stock Price Up 4.5% Time to Buy? (MarketBeat)
  • Perrigo Company Stock Price Forecast. Should You Buy PRGO? (StockInvest.us)

Follow PRGO in your daily brief

Each trading day at 5 PM ET we post what happened to PERRIGO Co plc and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow PRGO

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about PERRIGO Co plc stock

What does PERRIGO Co plc do?

PERRIGO Co plc trades on the New York Stock Exchange under the ticker PRGO. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

What is the ticker symbol for PERRIGO Co plc?

PERRIGO Co plc trades under the ticker PRGO on the New York Stock Exchange.

What is PERRIGO Co plc's market cap?

PERRIGO Co plc is a mid cap stock with a market cap of about 2.1 billion dollars.

How does PERRIGO Co plc make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves PRGO stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow PRGO stock every day?

Add PRGO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow PRGO daily

A free brief on PERRIGO Co plc and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare PRGO: PRGO vs NVS, PRGO vs AZN, PRGO vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed